Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| InspireMD, Inc.NSPR · Entity 7318 | CFO and CAO | January 07, 2025 | January 10, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
InspireMD, Inc.
Report date January 07, 2025 · Filed January 10, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,112,460 |
Reported balance
After 2025-01-07 transaction · row 1
1 source rowRow 1 · 2025-01-07 · Grant · Acquired 232,616 · Balance 1,112,460 F1: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service. |
| Options to purchase common stock (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.71 · Expires 2035-01-07 | Direct | 417,706 |
Reported balance
After 2025-01-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-01-07 · Grant · Acquired 106,218 · Balance 417,706 F2: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service.
F2: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 106,218 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001493152-25-001730 · ownership.xml · derivative · entry 2 Shore Craig · CIK 0001517387 · CFO and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 417,706 Underlying: Common Stock · 106,218 shares Expires 2035-01-07 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 232,616 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-001730 · ownership.xml · nonDerivative · entry 1 Shore Craig · CIK 0001517387 · CFO and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,112,460 F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 21:52 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 91,218 | $0.00 Strike: $3.14 | $0.00 |
DisclosureSEC source: 0001493152-24-003770 · ownership.xml · derivative · entry 2 Shore Craig · CIK 0001517387 · CFO and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 311,488 Underlying: Common Stock · 91,218 shares Expires 2034-01-23 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 21:52 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 238,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-003770 · ownership.xml · nonDerivative · entry 1 Shore Craig · CIK 0001517387 · CFO and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 879,844 F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 174,190 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001493152-23-018325 · ownership.xml · derivative · entry 2 Shore Craig · CIK 0001517387 · CFO and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,270 Underlying: Common Stock · 174,190 shares Expires 2033-05-17 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 522,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-018325 · ownership.xml · nonDerivative · entry 1 Shore Craig · CIK 0001517387 · CFO and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 641,219 F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 24,326 | $0.00 Strike: $4.09 | $0.00 |
DisclosureSEC source: 0001493152-21-028168 · ownership.xml · derivative · entry 2 Shore Craig · CIK 0001517387 · CFO and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,326 Underlying: Common Stock · 24,326 shares Expires 2031-11-10 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of November 10, 2022, November 10, 2023 and November 10, 2024, subject to the Reporting Person's continued service. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 72,978 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-028168 · ownership.xml · nonDerivative · entry 1 Shore Craig · CIK 0001517387 · CFO and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,639 F1 · shares: These restricted stock units vest and become exercisable in three equal annual installments, with 1/3 vesting on each of November 10, 2022, November 10, 2023 and November 10, 2024, subject to the Reporting Person's continued service. Read SEC document |
| November 10, 2021 Filed Jan 6, 2022 21:05 UTC Amendment | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 24,326 | $0.00 Strike: $4.09 | $0.00 |
DisclosureSEC source: 0001493152-22-000554 · ownership.xml · derivative · entry 2 Shore Craig · CIK 0001517387 · CFO and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,326 Underlying: Common Stock · 24,326 shares Expires 2031-11-10 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of November 10, 2022, November 10, 2023 and November 10, 2024, subject to the Reporting Person's continued service. Read SEC document |
| November 10, 2021 Filed Jan 6, 2022 21:05 UTC Amendment | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 72,978 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-000554 · ownership.xml · nonDerivative · entry 1 Shore Craig · CIK 0001517387 · CFO and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,639 F1 · shares: These shares of common stock vest and become exercisable in three equal annual installments, with 1/3 vesting on each of November 10, 2022, November 10, 2023 and November 10, 2024, subject to the Reporting Person's continued service. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 10:20 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOption to Purchase Common Stock · Derivative | 100,000 | $0.00 Strike: $0.46 | $0.00 |
DisclosureSEC source: 0001493152-21-009318 · ownership.xml · derivative · entry 2 Shore Craig · CIK 0001517387 · CFO and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,289 Underlying: Common Stock · 100,000 shares Expires 2031-04-19 F2 · derivative.exercise_date: These options vest and become exercisable in three equal installments, with 1/3 vesting on each of April 19, 2022, April 19, 2023 and April 19, 2024, subject to the Reporting Person's continued service. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 17:02 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 226,278 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001493152-20-017131 · ownership.xml · derivative · entry 2 Shore Craig · CIK 0001517387 · CFO AND CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,289 Underlying: Common Stock · 226,278 shares Expires 2030-08-31 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 17:02 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 678,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-017131 · ownership.xml · nonDerivative · entry 1 Shore Craig · CIK 0001517387 · CFO AND CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 684,849 F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 21:48 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-001390 · ownership.xml · nonDerivative · entry 1 Shore Craig · CIK 0001517387 · CFO AND CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,532 Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 21:30 UTC Amendment | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-001457 · ownership.xml · nonDerivative · entry 1 Shore Craig · CIK 0001517387 · CFO AND CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,523 F1 · security: On February 5, 2019, the reporting person filed a Form 4 which inadvertently reported that the reporting person beneficially owned 300,532 shares following the reported transaction. In fact, as reported in this amendment, the reporting person beneficially owns 300,523 shares following the reported transaction. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.